Shanghai Pharma Plans $1.2 Billion IPO On Hong Kong Market
This article was originally published in PharmAsia News
Executive Summary
China's Shanghai Pharmaceuticals Holding plans to raise $1.2 billion on the Hong Kong market, half of the proceeds to cover the cost of acquiring other companies